Clinical Trials in Los Angeles

Showing 2161-2180 of 14,465 trials

A Study of Select Drug Combinations in Adult Patients With Advanced/Metastatic BRAF V600 Colorectal Cancer

NCT04294160

A phase Ib, open-label platform study of select drug combinations chosen in order to characterize safety and tolerability of each treatment arm tested and to identify recommended doses and regimens for future studies.

BRAF V600 Colorectal Cancer

Novartis Pharmaceuticals122 participantsStarted Jul 2020

Los Angeles, California, United States • Boston, Massachusetts, United States • Nashville, Tennessee, United States +15 more locations

RECRUITINGPhase 3< 1 mile

A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age

NCT07300839

This study is designed to find out how well the COVID-19 vaccine protects people 50 to 64, who don't have any serious health problems, compared to a group that receives a vaccine that doesn't contain an ingredient to protect against COVID-19 (placebo).

COVID-19SARS-COV-2 Infection

BioNTech SE25,500 participantsStarted Dec 2025

Anniston, Alabama, United States • Athens, Alabama, United States • Birmingham, Alabama, United States +205 more locations

A Study of Select Drug Combinations in Adult Patients With Advanced/Metastatic BRAF V600 Colorectal Cancer

A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age

Find Trials by Condition in Los Angeles

Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL

Phase 2 Study of MGL-3196 in Patients With Non-Alcoholic Steatohepatitis (NASH)

INCB000928 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Anemia Due to Myeloproliferative Disorders

SP Thoracic IDE Study

Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC)

Tensi+ for Treating Overactive Bladder: A Randomized Controlled Trial

A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis

Oncolytic Adenovirus TILT-123 With Pembrolizumab as Treatment for Refractory Non-Small Cell Lung Cancer

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

Evaluation of the Dexmedetomidine Transdermal Systems for Postoperative Analgesia Following Abdominoplasty

SpineTRACK Registry - Spinal Outcomes Registry

An Observational Study of Patients With Moderate Parkinson's Disease

Stroke Thrombectomy and Aneurysm Registry

A Study of HBI-8000 (Tucidinostat) With Pembrolizumab in Non-Small Cell Lung Cancer

Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease

Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD

Neuroprognostication Bias: A Collaboration to Reduce the Impact of Self-fulfilling Prophecy in Cardiac ARrEst

Ribociclib and Letrozole Treatment in Ovarian Cancer